Type 4 Cyclic Nucleotide Phosphodiesterase (PDE4)

Type 4 cyclic nucleotide phosphodiesterases (PDE4) are a family of enzymes that specifically hydrolyze and degrade cyclic adenosine monophosphate (cAMP), a key second messenger involved in intracellular signaling. By regulating cAMP levels, PDE4 enzymes play critical roles in modulating cellular responses to hormones and neurotransmitters, particularly within the brain, immune system, and cardiovascular tissues. The PDE4 family consists of four subfamilies: PDE4A, PDE4B, PDE4C, and PDE4D. Alternative promoters, transcriptional start sites, and mRNA splicing generate over 25 isoforms across these subfamilies. All functional forms of PDE4 are dimers; each monomer contains two upstream conserved regions (UCRs) and a C-terminal catalytic domain responsible for cAMP hydrolysis. Regulation occurs through dimerization-dependent mechanisms unique to long forms involving UCR domains and post-translational modifications such as phosphorylation.

Inhibition of PDE4 increases intracellular cAMP levels, leading to anti-inflammatory effects.